Page last updated: 2024-09-03

2-(2,3-dicarboxycyclopropyl)glycine and Psychotic Disorders

2-(2,3-dicarboxycyclopropyl)glycine has been researched along with Psychotic Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barda, D; Britton, TC; Emkey, R; Hornback, WJ; Jagdmann, GE; Johnson, MP; McKinzie, DL; Nisenbaum, ES; Schoepp, DD; Tizzano, JP1

Other Studies

1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and Psychotic Disorders

ArticleYear
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
    Psychopharmacology, 2005, Volume: 179, Issue:1

    Topics: Animals; Anxiety; Cyclopropanes; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glycine; Humans; Male; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Motor Activity; Phencyclidine; Psychotic Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission

2005